Pacira BioSciences, Inc.
PCRX
$23.00
-$0.18-0.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 59.57% | 78.13% | -69.86% | 212.07% | -200.73% |
| Total Depreciation and Amortization | 2.94% | -20.53% | 71.07% | -42.96% | 29.95% |
| Total Amortization of Deferred Charges | 0.00% | 0.17% | -15.54% | -21.79% | 0.58% |
| Total Other Non-Cash Items | 10.94% | 17,116.44% | -100.13% | 117.20% | 362.45% |
| Change in Net Operating Assets | 242.58% | -178.64% | 191.95% | 56.60% | -1,275.94% |
| Cash from Operations | 123.75% | -41.22% | -28.18% | 406.44% | -66.12% |
| Capital Expenditure | 50.95% | -1,149.54% | 94.37% | -43.49% | 68.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -41.80% | 15.08% | -58.83% | -26.79% | 17,213.46% |
| Cash from Investing | -39.51% | 0.56% | -55.67% | -29.84% | 342.55% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 98.37% | -8,066.29% | -33.31% |
| Issuance of Common Stock | 108,850.00% | -99.88% | 14,250.00% | -99.24% | -- |
| Repurchase of Common Stock | 91.12% | -12.42% | 3.31% | 9.53% | -30,465.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.77% | -- | -- |
| Cash from Financing | 87.12% | -15.00% | 79.94% | -347.75% | -1,820.67% |
| Foreign Exchange rate Adjustments | -100.00% | 109.18% | -411.28% | -34.80% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 532.40% | -229.97% | 107.17% | -1,006.10% | 146.84% |